Soho Global Health Tbk PT
IDX:SOHO
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
458
765
|
| Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Soho Global Health Tbk PT
Soho Global Health Tbk PT
Short-Term Debt
Soho Global Health Tbk PT
Short-Term Debt Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Short-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Soho Global Health Tbk PT
IDX:SOHO
|
Short-Term Debt
Rp0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
T
|
Tempo Scan Pacific Tbk PT
IDX:TSPC
|
Short-Term Debt
Rp873.2B
|
CAGR 3-Years
28%
|
CAGR 5-Years
14%
|
CAGR 10-Years
25%
|
|
|
Kalbe Farma Tbk PT
IDX:KLBF
|
Short-Term Debt
Rp560.2B
|
CAGR 3-Years
64%
|
CAGR 5-Years
27%
|
CAGR 10-Years
-1%
|
|
|
Darya-Varia Laboratoria Tbk PT
IDX:DVLA
|
Short-Term Debt
Rp0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Pyridam Farma Tbk PT
IDX:PYFA
|
Short-Term Debt
Rp1.7T
|
CAGR 3-Years
293%
|
CAGR 5-Years
164%
|
CAGR 10-Years
51%
|
|
|
Kimia Farma Tbk PT
IDX:KAEF
|
Short-Term Debt
Rp4.1T
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
29%
|
|
Soho Global Health Tbk PT
Glance View
PT SOHO Global Health engages in the provision of healthcare services. The company is headquartered in Jakarta, Dki Jakarta and currently employs 2,373 full-time employees. The company went IPO on 2020-09-08. The firm operates through five segments: Distribution, Professional product, Consumer health, Alliance and Others. Its brands include Curcuma Plus, Curcuma Plus Milk, Imboost, Fitkom, Diapet, Laxing, Lelap, Asthma Soho and Sohobion. Curcuma Plus is a kid’s multivitamin that contains curcuma and fish oil. Curcuma Plus Milk is a growing up milk for kids. Imboost is a supplement that supports immune system. Fitkom offers kids multivitamins in gummy and tablet format. Diapet is an anti-diarrheal medicine. Laxing is a medicine for healthy digestion and bowel movement. Lelap is a medicine to alleviate sleep disorders. Asthma Soho is an asthma remedy. Sohobion is a neurotropic vitamin supplement to maintain neurological health. Its product portfolio ranged from wound care, hospital general care, surgery, orthopedics and in-vitro diagnostics.
See Also
What is Soho Global Health Tbk PT's Short-Term Debt?
Short-Term Debt
0
IDR
Based on the financial report for Dec 31, 2023, Soho Global Health Tbk PT's Short-Term Debt amounts to 0 IDR.
You don't have any saved screeners yet
